| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6831b19bfc354357342f7c7da79fc162 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097 |
| filingDate |
1985-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1989-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1690fc564ad17f85e265db92069b6db6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719616654f04ab0f54f759afc5b90e6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb23a4105cecf5d0672e82a5401e3a3e |
| publicationDate |
1989-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1248698-A |
| titleOfInvention |
Dihydroorotic acid derivative and processes for preparing the same |
| abstract |
Abstract: The invention provides 1-methyl-4,5-dihydroorotyl-histidyl-prolinamide and pharmaceutically acceptable acid addition salts thereof, processes for the preparation of these compounds and pharmaceutical compositions containing them. The prolinamide and the pharmaceutically acceptable acid addition salts thereof are useful for the treatment of central nervous system disorders. |
| priorityDate |
1984-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |